跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,120 条关于
“SK Inc.”
全部
41,120
临床试验
11,242
药物
1,742
机构
6,173
资讯
21,963
6个月前
SK Biopharmaceuticals Acquires Full Control of U.S. R&D Unit with $36 Million Investment to Advance Cancer Pipeline
6个月前
SK pharmteco Commits $100 Million to Strengthen Viral Vector Manufacturing Capabilities
5个月前
SK Life Science to Present Comprehensive Cenobamate Data and Patient-Provider Communication Study at AAN 2026
去年
Sodium Channel Blockers Pipeline Surges with 20+ Pharmaceutical Companies Developing Novel Therapies
去年
Bipolar Disorder Pipeline Shows Promise with 22+ Emerging Therapies
去年
Cenobamate Shows Strong Efficacy in Northeast Asian Epilepsy Patients in Phase 3 Trial
去年
SK Bioscience Secures Landmark Victory Against Moderna in Korean mRNA Patent Dispute
9个月前
Vaxxas Secures TGA Manufacturing License for Revolutionary Microarray Patch Vaccine Technology
前天
Japan Approves Ono's XCOPRI (Cenobamate) for Partial-Onset Seizures After Phase 3 Win
去年
Ferring Expands Adstiladrin Production Capacity with New Facility in Finland
第 1 页,共 2197 页
上一页
下一页